Adenosine Triphosphate (ATP) Assays Market Growth Outlook Through 2024-2033

Overview and Scope
Adenosine triphosphate (ATP) assays are analytical procedures for determining the concentrations of ATP in biological materials. ATP is an energy-carrying molecule found in all living creatures’ cells that extracts chemical energy from the breakdown of food molecules and uses it to power other cellular operations. This assay monitors cellular energy state and function and is an essential tool in research, diagnostics, and medication discovery.

Sizing and Forecast
The adenosine triphosphate (atp) assays market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to biomedical research advancements, drug discovery and development, rise in adoption in clinical diagnostics, environmental monitoring requirements, increased focus on cell-based assays..

The adenosine triphosphate (atp) assays market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to continued growth in biopharmaceutical industry, expansion of personalized medicine approaches, increased emphasis on food and beverage safety, technological innovations in assay platforms, growing application in industrial processes.. Major trends in the forecast period include advancements in atp detection technologies, rising demand for high-throughput screening, integration in clinical diagnostics, emphasis on food and beverage safety testing, application in sports and performance monitoring.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/adenosine-triphosphate-atp-assays-global-market-report

Segmentation & Regional Insights
The adenosine triphosphate (atp) assays market covered in this report is segmented –

1) By Type: Luminometric ATP (Adenosine Triphosphate) Assays, Enzymatic ATP (Adenosine Triphosphate) Assays, Bioluminescence Resonance Energy Transfer (BRET) ATP (Adenosine Triphosphate) Assays, Cell-Based ATP (Adenosine Triphosphate) Assays, Other Types
2) By Component: Consumables And Accessories, Instruments
3) By Application: Drug Discovery And Development, Clinical Diagnostics, Environmental Testing, Food Safety And Quality Testing, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Food and Beverage Industry, Hospitals And Diagnostics Laboratories, Academic And Research Institutions

North America was the largest region in the adenosine triphosphate (ATP) assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adenosine triphosphate (atp) assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10767&type=smp

Major Driver Impacting Market Growth
The increasing frequency of cancer, chronic, and infectious diseases is expected to propel the growth of the adenosine triphosphate (ATP) assay market going forward. Cancer is characterized by uncontrolled cell growth, which can invade and damage surrounding tissues and potentially spread to other body parts. Chronic diseases are stable conditions that typically progress slowly and persist over an extended period. Infectious diseases are those caused by pathogenic microorganisms that can be spread from person to person, such as bacteria, viruses, fungi, or parasites. ATP assays provide a valuable tool in the diagnostics of these diseases by assessing cellular viability, detecting microbial contamination, evaluating treatment efficacy, and monitoring metabolic and mitochondrial dysfunction. For instance, in October 2022, World Health Organization, a Switzerland-based specialized health agency of the United Nations, roughly 10.6 million people were ill with tuberculosis (TB) in 2021, where 1.6 million people died from TB (including 187 000 HIV positive people). Moreover, in 2021, according to the International Diabetes Federation, a Belgium-based international organization working for the diabetic community, approximately 537 million adults have diabetes, predicted to grow to 783 million by 2045. Therefore, the increasing frequency of cancer, chronic, and infectious diseases propels the adenosine triphosphate (ATP) assay market.

Key Industry Players
Major companies operating in the adenosine triphosphate (atp) assays market report are Merck KGaA, Thermo Fisher Scientific Inc., PerkinElmer Inc., Lonza Group, Promega Corporation, Agilent Technologies Inc., Abcam plc, Danaher Corporation, 3M Co., Geno Technology Inc., NEOGEN Corporation, Biomerieux SA, AAT Bioquest Inc., MBL International Corporation, Charm Sciences Inc., Cell Signaling Technology Inc., Cayman Chemical Company, Vazyme Biotech Co. Ltd., SignalChem Lifesciences Corporation, Kaneka Corporation, Novus Biologicals LLC, NANOGEN Biotechnologies Inc., Nacalai Tesque Inc., MoBiTec GmbH, Lumigen Inc., Jena Bioscience GmbH, Goryo Chemical Inc., Cosmo Bio Co. Ltd., BPS Bioscience Inc., BioTek Instruments Inc.

The adenosine triphosphate (atp) assays market report table of contents includes:

1. Executive Summary

2. Adenosine Triphosphate (ATP) Assays Market Characteristics

3. Adenosine Triphosphate (ATP) Assays Market Trends And Strategies

4. Adenosine Triphosphate (ATP) Assays Market – Macro Economic Scenario

5. Global Adenosine Triphosphate (ATP) Assays Market Size and Growth
.
.
.

31. Global Adenosine Triphosphate (ATP) Assays Market Competitive Benchmarking

32. Global Adenosine Triphosphate (ATP) Assays Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Adenosine Triphosphate (ATP) Assays Market

34. Adenosine Triphosphate (ATP) Assays Market Future Outlook and Potential Analysis

35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model